Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Trader J's Inner Circle -- Ignore unavailable to you. Want to Upgrade?

To: Trader J who wrote (8733)	2/11/1999 4:52:00 PM
From: ArtAlley	Respond to of 56532

ASCT question: Doesn't the approval of two new drugs have to be worth at a minimum of 25 million dollars( and probably much more). This would equal at least $12+ dollars a share(and probably much more).I base this on the fact that I remember reading somewhere that they recently sold off one of their older drugs for 12 million dollars. And these estimates really seems VERY low for newly approved drugs.

To: Trader J who wrote (8733)	2/11/1999 4:58:00 PM
From: zora	Read Replies (5) \| Respond to of 56532

ALL, ASCT Okay first, the announcement will be forth coming and we will all make lots of money. Second, it is a pretty good company in its own right. Thirdly, the market and mood are up. There will be no need to worry about what to sell at because the takeover price will be set and we just need to collect all the money. Can't wait to see all your happy faces in Vegas :) zora